NCT03561129 (Operator) is a clinical trial of Embryo transfer in Sterility, sponsored by Istituto Clinico Humanitas.

Who is sponsoring NCT03561129?

NCT03561129 is sponsored by Istituto Clinico Humanitas.

What drugs are being tested in NCT03561129?

Interventions in NCT03561129: Embryo transfer.

Is NCT03561129 still recruiting?

NCT03561129 is currently completed. Last updated 20 June 2018.

Last reviewed 2018-06-20 · How we verify

NCT03561129: Operator

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Embryotransfer Operator and Pregnancy Rate

Completed Last updated 20 June 2018

What this trial tests

trial testing Embryo transfer in Sterility in 200,000 participants. Completed in 31 December 2017.

Timeline

1 January 1997

Primary endpoint
31 December 2016

31 December 2017

Quick facts

Lead sponsor	Istituto Clinico Humanitas
Status	Completed
Study type	OBSERVATIONAL
Enrollment	200,000
Start date	1 January 1997
Primary completion	31 December 2016
Estimated completion	31 December 2017

Drugs / interventions tested

Embryo transfer

Conditions studied

Sterility — all drugs for Sterility →

Sponsor

Istituto Clinico Humanitas

Who can join

Adults 18 to 48, female only, with Sterility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Several studies had analyzed the correlation between embryo transfer operator experience and implantation, clinical pregnancy, abortion and delivery rate. The aim of the present study is determining if the probabilities of embryo implantation and pregnancy are associated to the operator performing the embryo transfer. This study allows following more than 30 different operators in a global period of 20 years with almost 20,000 procedures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

The human factor: does the operator performing the embryo transfer significantly impact the cycle outcome?
Cirillo F, Patrizio P, Baccini M, Morenghi E, et al · · 2020 · cited 25× · PMID 32100020 · DOI 10.1093/humrep/dez290

Verify or expand the search:

Other trials of Embryo transfer

Trials testing the same drug.

NCT06859944 — Prospective Randomized Non-Inferiority Study Comparing Natural Cycle Frozen Embryo Transfer (NC-FET) to a New Type of En · recruiting
NCT06133803 — Lovenox With Aspirin in Thawed Blastocyst Transfer · Phase 4 · unknown
NCT05980091 — Optimal Timing of Euploid Day 6 Blastocyst Transfer in Frozen HRT Cycles, Day 6 or Day 7 of Progesterone Administration. · Phase 1 · recruiting
NCT05969795 — Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support · Phase 1 · recruiting
NCT04210414 — Cleave-stage Transfer on Day 3 Versus Day 5 Transfer When Only One Embryo Available · NA · terminated

Other Istituto Clinico Humanitas trials

Trials by the same sponsor.

NCT06944288 — Microbiota as Early Diagnostic and predictivE Factor for Osteoarthritic Degeneration and Microbial Contamination · NA · not yet recruiting
NCT07358247 — Postoperative Outcomes of Single-stapled Anastomosis Combined With Transanal Natural Orifice Specimen Extraction · not yet recruiting
NCT07362342 — RIght VEntricle Response to Major Lung Resection in VATS and Robotic Surgery · not yet recruiting
NCT07346274 — Intra-operative Hypotension and Post-operative Lactate Level After Pancreatic-duodenectomy. · enrolling by invitation
NCT07491419 — The Impact of Fast Antimicrobial Sensitivity Testing Tools on Stewardship Antibiotic and Clinical Outcome (ACT-FAST) · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03561129 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istituto Clinico Humanitas
Last refreshed: 20 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03561129.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing